Novo Nordisk A/S, now Europes most valuable company with a market capitalization of roughly $454.5 billion as of Oct
As with all medications, patients should report any suspected side effects to their healthcare provider or directly to the MHRA through the Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
This article is intended for informational and research-planning purposes only
Abi Aad S, Pierce M, Barmaimon G, Farhat FS, Benjo A, Mouhayar E
They were initially developed to manage type 2 diabetes, but are now being explored for a broader range of uses, most popularly, in weight management but also importantly, in cardiovascular health
Self-reported community sources describe injection-site rotation and slower injection speeds reducing severity